Action Point Financial Planning’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,850
Closed -$88.4K – 1837
2026
Q2
$88.4K Buy
+1,850
New +$79.5K 0.01% 638

Other funds holding NVO

Action Point Financial Planning's NVO Position: Q3 2026 in Review

Action Point Financial Planning sold out of Novo Nordisk (NVO) in Q3 2026, closing a stake of 1,850 shares — an estimated $88.4K sold.

Action Point Financial Planning first reported a position in NVO in Q2 2026 and held it in 1 quarter. The position peaked at $88.4K in Q2 2026. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Action Point Financial Planning reported no remaining Novo Nordisk position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 1,850 Novo Nordisk shares in Q3 2026, an estimated $88.4K.
  • Action Point Financial Planning first reported a position in Novo Nordisk in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Novo Nordisk position peaked at $88.4K in Q2 2026.
  • 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.